USE OF GLP-1 RECEPTOR AGONISTS AND / OR DPP-IV INHIBITORS IN COMBINATION WITH PROTON PUMP INHIBITORS AND PPAR AGONISTS FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF DIABETES TYPE I I AND IMPAIRED PANCREATIC BETA-CELL FUNCTION

摘要

Methods for treating diabetes by increasing the insulin secretion by administration of a GLP-1 receptor agonist and/or a DPP-IV inhibitor in combination with a proton pump inhibitor and optionally a PPAR agonist are provided.